#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Folic acid ( FA ) is a known water-soluble B-vitamin comprising three sub-components : A pterin ring , p-aminobenzoyl residue , and L-glutamic acid (
3-1	17-22	Folic	person|substance[4]	new|new[4]	coref|coref	3-7[6_4]|3-7[6_4]
3-2	23-27	acid	substance[4]	new[4]	_	_
3-3	28-29	(	_	_	_	_
3-4	30-32	FA	abstract	new	coref	6-8
3-5	33-34	)	_	_	_	_
3-6	35-37	is	_	_	_	_
3-7	38-39	a	substance[6]	giv[6]	appos	3-23[13_6]
3-8	40-45	known	substance[6]	giv[6]	_	_
3-9	46-59	water-soluble	substance[6]	giv[6]	_	_
3-10	60-69	B-vitamin	substance[6]	giv[6]	_	_
3-11	70-80	comprising	_	_	_	_
3-12	81-86	three	abstract[7]	new[7]	appos	3-15[10_7]
3-13	87-101	sub-components	abstract[7]	new[7]	_	_
3-14	102-103	:	_	_	_	_
3-15	104-105	A	object[9]|abstract[10]	new[9]|giv[10]	_	_
3-16	106-112	pterin	person|object[9]|abstract[10]	new|new[9]|giv[10]	_	_
3-17	113-117	ring	object[9]|abstract[10]	new[9]|giv[10]	_	_
3-18	118-119	,	abstract[10]	giv[10]	_	_
3-19	120-134	p-aminobenzoyl	abstract[10]|substance|substance[12]	giv[10]|new|new[12]	_	_
3-20	135-142	residue	abstract[10]|substance[12]	giv[10]|new[12]	_	_
3-21	143-144	,	abstract[10]	giv[10]	_	_
3-22	145-148	and	abstract[10]	giv[10]	_	_
3-23	149-159	L-glutamic	abstract[10]|substance[13]	giv[10]|giv[13]	_	_
3-24	160-164	acid	abstract[10]|substance[13]	giv[10]|giv[13]	_	_
3-25	165-166	(	_	_	_	_

#Text=Figure 1
4-1	167-173	Figure	object[14]	new[14]	ana	6-1[0_14]
4-2	174-175	1	object[14]	new[14]	_	_

#Text=) .
5-1	176-177	)	_	_	_	_
5-2	178-179	.	_	_	_	_

#Text=It is linked with different diseases ; FA prevents birth defects of the brain and spinal cord , especially spina bifida , and decreases serum homocysteine levels , reducing the risk of heart diseases .
6-1	180-182	It	object	giv	_	_
6-2	183-185	is	_	_	_	_
6-3	186-192	linked	_	_	_	_
6-4	193-197	with	_	_	_	_
6-5	198-207	different	abstract[16]	new[16]	coref	6-33[26_16]
6-6	208-216	diseases	abstract[16]	new[16]	_	_
6-7	217-218	;	_	_	_	_
6-8	219-221	FA	substance	giv	coref	7-1
6-9	222-230	prevents	_	_	_	_
6-10	231-236	birth	event|abstract[19]	new|new[19]	_	_
6-11	237-244	defects	abstract[19]	new[19]	_	_
6-12	245-247	of	abstract[19]	new[19]	_	_
6-13	248-251	the	abstract[19]|object[20]	new[19]|new[20]	_	_
6-14	252-257	brain	abstract[19]|object[20]	new[19]|new[20]	_	_
6-15	258-261	and	abstract[19]	new[19]	_	_
6-16	262-268	spinal	abstract[19]|object[21]	new[19]|new[21]	_	_
6-17	269-273	cord	abstract[19]|object[21]	new[19]|new[21]	_	_
6-18	274-275	,	abstract[19]	new[19]	_	_
6-19	276-286	especially	abstract[19]	new[19]	_	_
6-20	287-292	spina	abstract[19]	new[19]	_	_
6-21	293-299	bifida	abstract[19]	new[19]	_	_
6-22	300-301	,	_	_	_	_
6-23	302-305	and	_	_	_	_
6-24	306-315	decreases	_	_	_	_
6-25	316-321	serum	substance|abstract[24]	new|new[24]	coref|coref	22-16|22-16
6-26	322-334	homocysteine	abstract|abstract[24]	new|new[24]	_	_
6-27	335-341	levels	abstract[24]	new[24]	_	_
6-28	342-343	,	_	_	_	_
6-29	344-352	reducing	_	_	_	_
6-30	353-356	the	abstract[25]	new[25]	_	_
6-31	357-361	risk	abstract[25]	new[25]	_	_
6-32	362-364	of	abstract[25]	new[25]	_	_
6-33	365-370	heart	abstract[25]|abstract[26]	new[25]|giv[26]	_	_
6-34	371-379	diseases	abstract[25]|abstract[26]	new[25]|giv[26]	_	_
6-35	380-381	.	_	_	_	_

#Text=FA is an essential vitamin that is nowadays prescribed to pregnant women and is indicated in the prevention of certain types of anemia .
7-1	382-384	FA	substance	giv	coref	7-3[28_0]
7-2	385-387	is	_	_	_	_
7-3	388-390	an	substance[28]	giv[28]	coref	8-1[0_28]
7-4	391-400	essential	substance[28]	giv[28]	_	_
7-5	401-408	vitamin	substance[28]	giv[28]	_	_
7-6	409-413	that	_	_	_	_
7-7	414-416	is	_	_	_	_
7-8	417-425	nowadays	_	_	_	_
7-9	426-436	prescribed	_	_	_	_
7-10	437-439	to	_	_	_	_
7-11	440-448	pregnant	person[29]	new[29]	_	_
7-12	449-454	women	person[29]	new[29]	_	_
7-13	455-458	and	_	_	_	_
7-14	459-461	is	_	_	_	_
7-15	462-471	indicated	_	_	_	_
7-16	472-474	in	_	_	_	_
7-17	475-478	the	event[30]	new[30]	_	_
7-18	479-489	prevention	event[30]	new[30]	_	_
7-19	490-492	of	event[30]	new[30]	_	_
7-20	493-500	certain	event[30]|abstract[31]	new[30]|new[31]	_	_
7-21	501-506	types	event[30]|abstract[31]	new[30]|new[31]	_	_
7-22	507-509	of	event[30]|abstract[31]	new[30]|new[31]	_	_
7-23	510-516	anemia	event[30]|abstract[31]|abstract	new[30]|new[31]|new	_	_
7-24	517-518	.	_	_	_	_

#Text=FA is also used in bioimaging as an element of orientation toward cancer cells , as folate receptors are highly over-expressed on the surface of many tumors .
8-1	519-521	FA	substance	giv	coref	9-1
8-2	522-524	is	_	_	_	_
8-3	525-529	also	_	_	_	_
8-4	530-534	used	_	_	_	_
8-5	535-537	in	_	_	_	_
8-6	538-548	bioimaging	_	_	_	_
8-7	549-551	as	_	_	_	_
8-8	552-554	an	_	_	_	_
8-9	555-562	element	_	_	_	_
8-10	563-565	of	_	_	_	_
8-11	566-577	orientation	abstract[34]	new[34]	_	_
8-12	578-584	toward	abstract[34]	new[34]	_	_
8-13	585-591	cancer	abstract[34]|abstract|object[36]	new[34]|new|new[36]	_	_
8-14	592-597	cells	abstract[34]|object[36]	new[34]|new[36]	_	_
8-15	598-599	,	_	_	_	_
8-16	600-602	as	_	_	_	_
8-17	603-609	folate	substance|substance[38]	new|new[38]	_	_
8-18	610-619	receptors	substance[38]	new[38]	_	_
8-19	620-623	are	_	_	_	_
8-20	624-630	highly	_	_	_	_
8-21	631-645	over-expressed	_	_	_	_
8-22	646-648	on	_	_	_	_
8-23	649-652	the	place[39]	new[39]	_	_
8-24	653-660	surface	place[39]	new[39]	_	_
8-25	661-663	of	place[39]	new[39]	_	_
8-26	664-668	many	place[39]|object[40]	new[39]|new[40]	_	_
8-27	669-675	tumors	place[39]|object[40]	new[39]|new[40]	_	_
8-28	676-677	.	_	_	_	_

#Text=FA plays an important role in the proper development of physiological processes in the body .
9-1	678-680	FA	substance	giv	coref	10-9
9-2	681-686	plays	_	_	_	_
9-3	687-689	an	abstract[42]	new[42]	_	_
9-4	690-699	important	abstract[42]	new[42]	_	_
9-5	700-704	role	abstract[42]	new[42]	_	_
9-6	705-707	in	_	_	_	_
9-7	708-711	the	abstract[43]	new[43]	_	_
9-8	712-718	proper	abstract[43]	new[43]	_	_
9-9	719-730	development	abstract[43]	new[43]	_	_
9-10	731-733	of	abstract[43]	new[43]	_	_
9-11	734-747	physiological	abstract[43]|abstract[44]	new[43]|new[44]	_	_
9-12	748-757	processes	abstract[43]|abstract[44]	new[43]|new[44]	_	_
9-13	758-760	in	abstract[43]|abstract[44]	new[43]|new[44]	_	_
9-14	761-764	the	abstract[43]|abstract[44]|object[45]	new[43]|new[44]|new[45]	coref	10-1[46_45]
9-15	765-769	body	abstract[43]|abstract[44]|object[45]	new[43]|new[44]|new[45]	_	_
9-16	770-771	.	_	_	_	_

#Text=The human body is not able to synthesize FA , and its presence in foods such as spinach , cereals , citrus , rice , and beans may not be enough to meet the daily requirement for this vitamin .
10-1	772-775	The	object[46]	giv[46]	_	_
10-2	776-781	human	object[46]	giv[46]	_	_
10-3	782-786	body	object[46]	giv[46]	_	_
10-4	787-789	is	_	_	_	_
10-5	790-793	not	_	_	_	_
10-6	794-798	able	_	_	_	_
10-7	799-801	to	_	_	_	_
10-8	802-812	synthesize	_	_	_	_
10-9	813-815	FA	abstract	giv	ana	10-12
10-10	816-817	,	_	_	_	_
10-11	818-821	and	_	_	_	_
10-12	822-825	its	substance|abstract[49]	giv|new[49]	coref|coref	10-38[57_0]|10-38[57_0]
10-13	826-834	presence	abstract[49]	new[49]	_	_
10-14	835-837	in	abstract[49]	new[49]	_	_
10-15	838-843	foods	abstract[49]|substance[50]	new[49]|new[50]	coref	11-5[0_50]
10-16	844-848	such	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-17	849-851	as	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-18	852-859	spinach	abstract[49]|substance[50]|plant	new[49]|new[50]|new	_	_
10-19	860-861	,	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-20	862-869	cereals	abstract[49]|substance[50]|plant	new[49]|new[50]|new	_	_
10-21	870-871	,	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-22	872-878	citrus	abstract[49]|substance[50]|plant	new[49]|new[50]|new	_	_
10-23	879-880	,	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-24	881-885	rice	abstract[49]|substance[50]|substance	new[49]|new[50]|new	_	_
10-25	886-887	,	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-26	888-891	and	abstract[49]|substance[50]	new[49]|new[50]	_	_
10-27	892-897	beans	abstract[49]|substance[50]|plant	new[49]|new[50]|new	_	_
10-28	898-901	may	_	_	_	_
10-29	902-905	not	_	_	_	_
10-30	906-908	be	_	_	_	_
10-31	909-915	enough	_	_	_	_
10-32	916-918	to	_	_	_	_
10-33	919-923	meet	_	_	_	_
10-34	924-927	the	abstract[56]	new[56]	_	_
10-35	928-933	daily	abstract[56]	new[56]	_	_
10-36	934-945	requirement	abstract[56]	new[56]	_	_
10-37	946-949	for	abstract[56]	new[56]	_	_
10-38	950-954	this	abstract[56]|substance[57]	new[56]|giv[57]	coref	11-8[60_57]
10-39	955-962	vitamin	abstract[56]|substance[57]	new[56]|giv[57]	_	_
10-40	963-964	.	_	_	_	_

#Text=The daily consumption of foods fortified with FA , such as citrus beverages , can provide the amount required for human health .
11-1	965-968	The	abstract[58]	new[58]	_	_
11-2	969-974	daily	abstract[58]	new[58]	_	_
11-3	975-986	consumption	abstract[58]	new[58]	_	_
11-4	987-989	of	abstract[58]	new[58]	_	_
11-5	990-995	foods	abstract[58]|substance	new[58]|giv	_	_
11-6	996-1005	fortified	_	_	_	_
11-7	1006-1010	with	_	_	_	_
11-8	1011-1013	FA	abstract[60]	giv[60]	coref	12-11[0_60]
11-9	1014-1015	,	abstract[60]	giv[60]	_	_
11-10	1016-1020	such	abstract[60]	giv[60]	_	_
11-11	1021-1023	as	abstract[60]	giv[60]	_	_
11-12	1024-1030	citrus	abstract[60]|substance[61]	giv[60]|new[61]	coref	12-13[66_61]
11-13	1031-1040	beverages	abstract[60]|substance[61]	giv[60]|new[61]	_	_
11-14	1041-1042	,	_	_	_	_
11-15	1043-1046	can	_	_	_	_
11-16	1047-1054	provide	_	_	_	_
11-17	1055-1058	the	quantity[62]	new[62]	_	_
11-18	1059-1065	amount	quantity[62]	new[62]	_	_
11-19	1066-1074	required	_	_	_	_
11-20	1075-1078	for	_	_	_	_
11-21	1079-1084	human	abstract[63]	new[63]	_	_
11-22	1085-1091	health	abstract[63]	new[63]	_	_
11-23	1092-1093	.	_	_	_	_

#Text=Therefore , having a simple and fast method for determining FA in commercial beverages is of great interest .
12-1	1094-1103	Therefore	_	_	_	_
12-2	1104-1105	,	_	_	_	_
12-3	1106-1112	having	_	_	_	_
12-4	1113-1114	a	abstract[64]	new[64]	coref	16-6[89_64]
12-5	1115-1121	simple	abstract[64]	new[64]	_	_
12-6	1122-1125	and	abstract[64]	new[64]	_	_
12-7	1126-1130	fast	abstract[64]	new[64]	_	_
12-8	1131-1137	method	abstract[64]	new[64]	_	_
12-9	1138-1141	for	_	_	_	_
12-10	1142-1153	determining	_	_	_	_
12-11	1154-1156	FA	substance	giv	coref	13-13
12-12	1157-1159	in	_	_	_	_
12-13	1160-1170	commercial	substance[66]	giv[66]	coref	31-31[218_66]
12-14	1171-1180	beverages	substance[66]	giv[66]	_	_
12-15	1181-1183	is	_	_	_	_
12-16	1184-1186	of	_	_	_	_
12-17	1187-1192	great	abstract[67]	new[67]	_	_
12-18	1193-1201	interest	abstract[67]	new[67]	_	_
12-19	1202-1203	.	_	_	_	_

#Text=Different methods have been reported in the literature for the quantification of FA , including spectrophotometric methods , electrochemical techniques , high-performance liquid chromatography ( HPLC ) and ultrahigh HPLC , and ion chromatography .
13-1	1204-1213	Different	abstract[68]	new[68]	coref	13-16[72_68]
13-2	1214-1221	methods	abstract[68]	new[68]	_	_
13-3	1222-1226	have	_	_	_	_
13-4	1227-1231	been	_	_	_	_
13-5	1232-1240	reported	_	_	_	_
13-6	1241-1243	in	_	_	_	_
13-7	1244-1247	the	abstract[69]	new[69]	_	_
13-8	1248-1258	literature	abstract[69]	new[69]	_	_
13-9	1259-1262	for	abstract[69]	new[69]	_	_
13-10	1263-1266	the	abstract[69]|abstract[70]	new[69]|new[70]	_	_
13-11	1267-1281	quantification	abstract[69]|abstract[70]	new[69]|new[70]	_	_
13-12	1282-1284	of	abstract[69]|abstract[70]	new[69]|new[70]	_	_
13-13	1285-1287	FA	abstract[69]|abstract[70]|substance	new[69]|new[70]|giv	coref	16-23
13-14	1288-1289	,	abstract[69]|abstract[70]	new[69]|new[70]	_	_
13-15	1290-1299	including	abstract[69]|abstract[70]	new[69]|new[70]	_	_
13-16	1300-1318	spectrophotometric	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	coref	14-4[80_72]
13-17	1319-1326	methods	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-18	1327-1328	,	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-19	1329-1344	electrochemical	abstract[69]|abstract[70]|abstract[72]|abstract[73]	new[69]|new[70]|giv[72]|new[73]	_	_
13-20	1345-1355	techniques	abstract[69]|abstract[70]|abstract[72]|abstract[73]	new[69]|new[70]|giv[72]|new[73]	_	_
13-21	1356-1357	,	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-22	1358-1374	high-performance	abstract[69]|abstract[70]|abstract[72]|abstract[75]	new[69]|new[70]|giv[72]|new[75]	_	_
13-23	1375-1381	liquid	abstract[69]|abstract[70]|abstract[72]|substance|abstract[75]	new[69]|new[70]|giv[72]|new|new[75]	_	_
13-24	1382-1396	chromatography	abstract[69]|abstract[70]|abstract[72]|abstract[75]	new[69]|new[70]|giv[72]|new[75]	_	_
13-25	1397-1398	(	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-26	1399-1403	HPLC	abstract[69]|abstract[70]|abstract[72]|object	new[69]|new[70]|giv[72]|new	coref	13-29[77_0]
13-27	1404-1405	)	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-28	1406-1409	and	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-29	1410-1419	ultrahigh	abstract[69]|abstract[70]|abstract[72]|object[77]	new[69]|new[70]|giv[72]|giv[77]	_	_
13-30	1420-1424	HPLC	abstract[69]|abstract[70]|abstract[72]|object[77]	new[69]|new[70]|giv[72]|giv[77]	_	_
13-31	1425-1426	,	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-32	1427-1430	and	abstract[69]|abstract[70]|abstract[72]	new[69]|new[70]|giv[72]	_	_
13-33	1431-1434	ion	abstract[69]|abstract[70]|abstract[72]|abstract|object[79]	new[69]|new[70]|giv[72]|new|new[79]	_	_
13-34	1435-1449	chromatography	abstract[69]|abstract[70]|abstract[72]|object[79]	new[69]|new[70]|giv[72]|new[79]	_	_
13-35	1450-1451	.	_	_	_	_

#Text=In general , these methods are based on time-consuming reactions that involve laborious and slow procedures .
14-1	1452-1454	In	_	_	_	_
14-2	1455-1462	general	_	_	_	_
14-3	1463-1464	,	_	_	_	_
14-4	1465-1470	these	abstract[80]	giv[80]	coref	15-4[83_80]
14-5	1471-1478	methods	abstract[80]	giv[80]	_	_
14-6	1479-1482	are	_	_	_	_
14-7	1483-1488	based	_	_	_	_
14-8	1489-1491	on	_	_	_	_
14-9	1492-1506	time-consuming	abstract[81]	new[81]	_	_
14-10	1507-1516	reactions	abstract[81]	new[81]	_	_
14-11	1517-1521	that	_	_	_	_
14-12	1522-1529	involve	_	_	_	_
14-13	1530-1539	laborious	abstract[82]	new[82]	_	_
14-14	1540-1543	and	abstract[82]	new[82]	_	_
14-15	1544-1548	slow	abstract[82]	new[82]	_	_
14-16	1549-1559	procedures	abstract[82]	new[82]	_	_
14-17	1560-1561	.	_	_	_	_

#Text=In particular , the chromatographic methods require expensive equipment and the use of large volumes of organic solvents .
15-1	1562-1564	In	_	_	_	_
15-2	1565-1575	particular	_	_	_	_
15-3	1576-1577	,	_	_	_	_
15-4	1578-1581	the	abstract[83]	giv[83]	coref	17-1[98_83]
15-5	1582-1597	chromatographic	abstract[83]	giv[83]	_	_
15-6	1598-1605	methods	abstract[83]	giv[83]	_	_
15-7	1606-1613	require	_	_	_	_
15-8	1614-1623	expensive	object[84]	new[84]	_	_
15-9	1624-1633	equipment	object[84]	new[84]	_	_
15-10	1634-1637	and	_	_	_	_
15-11	1638-1641	the	abstract[85]	new[85]	_	_
15-12	1642-1645	use	abstract[85]	new[85]	_	_
15-13	1646-1648	of	abstract[85]	new[85]	_	_
15-14	1649-1654	large	abstract[85]|abstract[86]	new[85]|new[86]	_	_
15-15	1655-1662	volumes	abstract[85]|abstract[86]	new[85]|new[86]	_	_
15-16	1663-1665	of	abstract[85]|abstract[86]	new[85]|new[86]	_	_
15-17	1666-1673	organic	abstract[85]|abstract[86]|substance[87]	new[85]|new[86]|new[87]	_	_
15-18	1674-1682	solvents	abstract[85]|abstract[86]|substance[87]	new[85]|new[86]|new[87]	_	_
15-19	1683-1684	.	_	_	_	_

#Text=Therefore , the development of a simple , accurate , and low-cost method with high sensitivity and selectivity for the determination of FA is of great importance for monitoring the quality of food products .
16-1	1685-1694	Therefore	_	_	_	_
16-2	1695-1696	,	_	_	_	_
16-3	1697-1700	the	abstract[88]	new[88]	_	_
16-4	1701-1712	development	abstract[88]	new[88]	_	_
16-5	1713-1715	of	abstract[88]	new[88]	_	_
16-6	1716-1717	a	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-7	1718-1724	simple	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-8	1725-1726	,	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-9	1727-1735	accurate	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-10	1736-1737	,	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-11	1738-1741	and	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-12	1742-1750	low-cost	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-13	1751-1757	method	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-14	1758-1762	with	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-15	1763-1767	high	abstract[88]|abstract[89]|abstract[90]	new[88]|giv[89]|new[90]	coref	17-16[0_90]
16-16	1768-1779	sensitivity	abstract[88]|abstract[89]|abstract[90]	new[88]|giv[89]|new[90]	_	_
16-17	1780-1783	and	abstract[88]|abstract[89]	new[88]|giv[89]	_	_
16-18	1784-1795	selectivity	abstract[88]|abstract[89]|abstract[91]	new[88]|giv[89]|new[91]	coref	17-13[102_91]
16-19	1796-1799	for	abstract[88]|abstract[89]|abstract[91]	new[88]|giv[89]|new[91]	_	_
16-20	1800-1803	the	abstract[88]|abstract[89]|abstract[91]|abstract[92]	new[88]|giv[89]|new[91]|new[92]	coref	21-7[124_92]
16-21	1804-1817	determination	abstract[88]|abstract[89]|abstract[91]|abstract[92]	new[88]|giv[89]|new[91]|new[92]	_	_
16-22	1818-1820	of	abstract[88]|abstract[89]|abstract[91]|abstract[92]	new[88]|giv[89]|new[91]|new[92]	_	_
16-23	1821-1823	FA	abstract[88]|abstract[89]|abstract[91]|abstract[92]|substance	new[88]|giv[89]|new[91]|new[92]|giv	coref	21-10
16-24	1824-1826	is	_	_	_	_
16-25	1827-1829	of	_	_	_	_
16-26	1830-1835	great	abstract[94]	new[94]	_	_
16-27	1836-1846	importance	abstract[94]	new[94]	_	_
16-28	1847-1850	for	_	_	_	_
16-29	1851-1861	monitoring	_	_	_	_
16-30	1862-1865	the	abstract[95]	new[95]	_	_
16-31	1866-1873	quality	abstract[95]	new[95]	_	_
16-32	1874-1876	of	abstract[95]	new[95]	_	_
16-33	1877-1881	food	abstract[95]|substance[96]	new[95]|new[96]	_	_
16-34	1882-1890	products	abstract[95]|substance[96]	new[95]|new[96]	_	_
16-35	1891-1892	.	_	_	_	_

#Text=Fluorescence methods have gained considerable attention in recent years , due to their selectivity , sensitivity , easy sample preparation , and rapid analysis .
17-1	1893-1905	Fluorescence	abstract|abstract[98]	new|giv[98]	ana|coref|ana|coref	17-13[0_98]|22-23|17-13[0_98]|22-23
17-2	1906-1913	methods	abstract[98]	giv[98]	_	_
17-3	1914-1918	have	_	_	_	_
17-4	1919-1925	gained	_	_	_	_
17-5	1926-1938	considerable	abstract[99]	new[99]	_	_
17-6	1939-1948	attention	abstract[99]	new[99]	_	_
17-7	1949-1951	in	_	_	_	_
17-8	1952-1958	recent	time[100]	new[100]	coref	21-2[122_100]
17-9	1959-1964	years	time[100]	new[100]	_	_
17-10	1965-1966	,	_	_	_	_
17-11	1967-1970	due	_	_	_	_
17-12	1971-1973	to	_	_	_	_
17-13	1974-1979	their	abstract|abstract[102]	giv|giv[102]	coref|coref	21-5[123_0]|21-5[123_0]
17-14	1980-1991	selectivity	abstract[102]	giv[102]	_	_
17-15	1992-1993	,	_	_	_	_
17-16	1994-2005	sensitivity	abstract	giv	_	_
17-17	2006-2007	,	_	_	_	_
17-18	2008-2012	easy	abstract[104]	new[104]	_	_
17-19	2013-2019	sample	abstract[104]	new[104]	_	_
17-20	2020-2031	preparation	abstract[104]	new[104]	_	_
17-21	2032-2033	,	_	_	_	_
17-22	2034-2037	and	_	_	_	_
17-23	2038-2043	rapid	abstract[105]	new[105]	_	_
17-24	2044-2052	analysis	abstract[105]	new[105]	_	_
17-25	2053-2054	.	_	_	_	_

#Text=As a kind of new fluorophore , quantum dots ( QDs ) are a favorable alternative as they have advantages over conventional organic fluorescent dyes .
18-1	2055-2057	As	_	_	_	_
18-2	2058-2059	a	_	_	_	_
18-3	2060-2064	kind	abstract[106]|abstract[107]	new[106]|new[107]	ana|ana	18-18[0_107]|18-18[0_107]
18-4	2065-2067	of	abstract[106]|abstract[107]	new[106]|new[107]	_	_
18-5	2068-2071	new	abstract[106]|abstract[107]	new[106]|new[107]	_	_
18-6	2072-2083	fluorophore	abstract[106]|abstract[107]	new[106]|new[107]	_	_
18-7	2084-2085	,	abstract[107]	new[107]	_	_
18-8	2086-2093	quantum	abstract[107]|object[108]	new[107]|new[108]	_	_
18-9	2094-2098	dots	abstract[107]|object[108]	new[107]|new[108]	_	_
18-10	2099-2100	(	_	_	_	_
18-11	2101-2104	QDs	abstract	new	coref	20-1
18-12	2105-2106	)	_	_	_	_
18-13	2107-2110	are	_	_	_	_
18-14	2111-2112	a	abstract[110]	new[110]	_	_
18-15	2113-2122	favorable	abstract[110]	new[110]	_	_
18-16	2123-2134	alternative	abstract[110]	new[110]	_	_
18-17	2135-2137	as	_	_	_	_
18-18	2138-2142	they	abstract	giv	_	_
18-19	2143-2147	have	_	_	_	_
18-20	2148-2158	advantages	abstract[112]	new[112]	ana	19-1[0_112]
18-21	2159-2163	over	abstract[112]	new[112]	_	_
18-22	2164-2176	conventional	abstract[112]|object[113]	new[112]|new[113]	_	_
18-23	2177-2184	organic	abstract[112]|object[113]	new[112]|new[113]	_	_
18-24	2185-2196	fluorescent	abstract[112]|object[113]	new[112]|new[113]	_	_
18-25	2197-2201	dyes	abstract[112]|object[113]	new[112]|new[113]	_	_
18-26	2202-2203	.	_	_	_	_

#Text=They have unusual optical and electronic properties as a consequence of the quantum confinement effect .
19-1	2204-2208	They	abstract	giv	_	_
19-2	2209-2213	have	_	_	_	_
19-3	2214-2221	unusual	abstract[115]	new[115]	_	_
19-4	2222-2229	optical	abstract[115]	new[115]	_	_
19-5	2230-2233	and	abstract[115]	new[115]	_	_
19-6	2234-2244	electronic	abstract[115]	new[115]	_	_
19-7	2245-2255	properties	abstract[115]	new[115]	_	_
19-8	2256-2258	as	_	_	_	_
19-9	2259-2260	a	_	_	_	_
19-10	2261-2272	consequence	_	_	_	_
19-11	2273-2275	of	_	_	_	_
19-12	2276-2279	the	abstract[117]	new[117]	_	_
19-13	2280-2287	quantum	abstract[117]	new[117]	_	_
19-14	2288-2299	confinement	abstract|abstract[117]	new|new[117]	_	_
19-15	2300-2306	effect	abstract[117]	new[117]	_	_
19-16	2307-2308	.	_	_	_	_

#Text=QDs have been proven to be effective in different applications as biological biomarkers , sensors , drug delivery systems , and solar cells .
20-1	2309-2312	QDs	abstract	giv	coref	23-9
20-2	2313-2317	have	_	_	_	_
20-3	2318-2322	been	_	_	_	_
20-4	2323-2329	proven	_	_	_	_
20-5	2330-2332	to	_	_	_	_
20-6	2333-2335	be	_	_	_	_
20-7	2336-2345	effective	_	_	_	_
20-8	2346-2348	in	_	_	_	_
20-9	2349-2358	different	abstract[119]	new[119]	_	_
20-10	2359-2371	applications	abstract[119]	new[119]	_	_
20-11	2372-2374	as	abstract[119]	new[119]	_	_
20-12	2375-2385	biological	abstract[119]	new[119]	_	_
20-13	2386-2396	biomarkers	abstract[119]	new[119]	_	_
20-14	2397-2398	,	abstract[119]	new[119]	_	_
20-15	2399-2406	sensors	abstract[119]	new[119]	_	_
20-16	2407-2408	,	abstract[119]	new[119]	_	_
20-17	2409-2413	drug	abstract[119]|substance	new[119]|new	_	_
20-18	2414-2422	delivery	abstract[119]|abstract	new[119]|new	_	_
20-19	2423-2430	systems	abstract[119]	new[119]	_	_
20-20	2431-2432	,	abstract[119]	new[119]	_	_
20-21	2433-2436	and	abstract[119]	new[119]	_	_
20-22	2437-2442	solar	abstract[119]	new[119]	_	_
20-23	2443-2448	cells	abstract[119]	new[119]	_	_
20-24	2449-2450	.	_	_	_	_

#Text=In recent years , methods for the determination of FA based on the use of nanomaterials have been reported .
21-1	2451-2453	In	_	_	_	_
21-2	2454-2460	recent	time[122]	giv[122]	_	_
21-3	2461-2466	years	time[122]	giv[122]	_	_
21-4	2467-2468	,	_	_	_	_
21-5	2469-2476	methods	abstract[123]	giv[123]	_	_
21-6	2477-2480	for	abstract[123]	giv[123]	_	_
21-7	2481-2484	the	abstract[123]|abstract[124]	giv[123]|giv[124]	coref	22-40[147_124]
21-8	2485-2498	determination	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
21-9	2499-2501	of	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
21-10	2502-2504	FA	abstract[123]|abstract[124]|substance	giv[123]|giv[124]|giv	coref	22-43
21-11	2505-2510	based	_	_	_	_
21-12	2511-2513	on	_	_	_	_
21-13	2514-2517	the	abstract[126]	new[126]	_	_
21-14	2518-2521	use	abstract[126]	new[126]	_	_
21-15	2522-2524	of	abstract[126]	new[126]	_	_
21-16	2525-2538	nanomaterials	abstract[126]|object	new[126]|new	_	_
21-17	2539-2543	have	_	_	_	_
21-18	2544-2548	been	_	_	_	_
21-19	2549-2557	reported	_	_	_	_
21-20	2558-2559	.	_	_	_	_

#Text=Graphene oxide/Ag nanoparticle hybrids with surface-enhanced Raman spectroscopy ( SERS ) detection , a bovine serum albumin ( BSA)-modified gold nanocluster with fluorescence detection , and a ZrO2 nanoparticle-modified carbon paste electrode with voltammetry detection have been used in the determination of FA .
22-1	2560-2568	Graphene	animal|object[131]	new|new[131]	_	_
22-2	2569-2577	oxide/Ag	animal|object[131]	new|new[131]	_	_
22-3	2578-2590	nanoparticle	quantity|object[131]	new|new[131]	_	_
22-4	2591-2598	hybrids	object[131]	new[131]	_	_
22-5	2599-2603	with	object[131]	new[131]	_	_
22-6	2604-2620	surface-enhanced	object[131]|abstract[132]	new[131]|new[132]	appos	22-10[0_132]
22-7	2621-2626	Raman	object[131]|abstract[132]	new[131]|new[132]	_	_
22-8	2627-2639	spectroscopy	object[131]|abstract[132]	new[131]|new[132]	_	_
22-9	2640-2641	(	object[131]	new[131]	_	_
22-10	2642-2646	SERS	object[131]|abstract	new[131]|giv	coref	34-12[235_0]
22-11	2647-2648	)	object[131]	new[131]	_	_
22-12	2649-2658	detection	object[131]|abstract	new[131]|new	coref	22-23[141_0]
22-13	2659-2660	,	object[131]	new[131]	_	_
22-14	2661-2662	a	object[131]|object[137]	new[131]|new[137]	appos	22-19[139_137]
22-15	2663-2669	bovine	object[131]|place|object[137]	new[131]|new|new[137]	_	_
22-16	2670-2675	serum	object[131]|abstract|object[137]	new[131]|giv|new[137]	_	_
22-17	2676-2683	albumin	object[131]|object[137]	new[131]|new[137]	_	_
22-18	2684-2685	(	object[131]	new[131]	_	_
22-19	2686-2699	BSA)-modified	object[131]|object[139]	new[131]|giv[139]	_	_
22-20	2700-2704	gold	object[131]|substance|object[139]	new[131]|new|giv[139]	_	_
22-21	2705-2716	nanocluster	object[131]|object[139]	new[131]|giv[139]	_	_
22-22	2717-2721	with	object[131]|object[139]	new[131]|giv[139]	_	_
22-23	2722-2734	fluorescence	object[131]|object[139]|abstract|abstract[141]	new[131]|giv[139]|giv|giv[141]	coref|coref|coref|coref	22-34[146_141]|34-22|22-34[146_141]|34-22
22-24	2735-2744	detection	object[131]|object[139]|abstract[141]	new[131]|giv[139]|giv[141]	_	_
22-25	2745-2746	,	object[131]	new[131]	_	_
22-26	2747-2750	and	object[131]	new[131]	_	_
22-27	2751-2752	a	object[131]|object[144]	new[131]|new[144]	_	_
22-28	2753-2757	ZrO2	object[131]|abstract|object[144]	new[131]|new|new[144]	_	_
22-29	2758-2779	nanoparticle-modified	object[131]|object[144]	new[131]|new[144]	_	_
22-30	2780-2786	carbon	object[131]|object[144]	new[131]|new[144]	_	_
22-31	2787-2792	paste	object[131]|abstract|object[144]	new[131]|new|new[144]	_	_
22-32	2793-2802	electrode	object[131]|object[144]	new[131]|new[144]	_	_
22-33	2803-2807	with	object[131]|object[144]	new[131]|new[144]	_	_
22-34	2808-2819	voltammetry	object[131]|object[144]|abstract|abstract[146]	new[131]|new[144]|new|giv[146]	coref|coref	40-14[0_146]|40-14[0_146]
22-35	2820-2829	detection	object[131]|object[144]|abstract[146]	new[131]|new[144]|giv[146]	_	_
22-36	2830-2834	have	_	_	_	_
22-37	2835-2839	been	_	_	_	_
22-38	2840-2844	used	_	_	_	_
22-39	2845-2847	in	_	_	_	_
22-40	2848-2851	the	abstract[147]	giv[147]	coref	23-4[150_147]
22-41	2852-2865	determination	abstract[147]	giv[147]	_	_
22-42	2866-2868	of	abstract[147]	giv[147]	_	_
22-43	2869-2871	FA	abstract[147]|abstract	giv[147]|giv	coref	23-7
22-44	2872-2873	.	_	_	_	_

#Text=Other works show the determination of FA using QDs capped with thiolated ligands as thioglycolic ( TGA ) and mercaptopropionic ( MPA ) acids .
23-1	2874-2879	Other	abstract[149]	new[149]	coref	29-3[196_149]
23-2	2880-2885	works	abstract[149]	new[149]	_	_
23-3	2886-2890	show	_	_	_	_
23-4	2891-2894	the	abstract[150]	giv[150]	coref	30-16[205_150]
23-5	2895-2908	determination	abstract[150]	giv[150]	_	_
23-6	2909-2911	of	abstract[150]	giv[150]	_	_
23-7	2912-2914	FA	abstract[150]|object	giv[150]|giv	coref	25-5
23-8	2915-2920	using	_	_	_	_
23-9	2921-2924	QDs	abstract	giv	coref	24-25[163_0]
23-10	2925-2931	capped	_	_	_	_
23-11	2932-2936	with	_	_	_	_
23-12	2937-2946	thiolated	substance[153]	new[153]	_	_
23-13	2947-2954	ligands	substance[153]	new[153]	_	_
23-14	2955-2957	as	substance[153]	new[153]	_	_
23-15	2958-2970	thioglycolic	substance[153]	new[153]	_	_
23-16	2971-2972	(	_	_	_	_
23-17	2973-2976	TGA	abstract	new	_	_
23-18	2977-2978	)	_	_	_	_
23-19	2979-2982	and	_	_	_	_
23-20	2983-3000	mercaptopropionic	_	_	_	_
23-21	3001-3002	(	_	_	_	_
23-22	3003-3006	MPA	object	new	_	_
23-23	3007-3008	)	_	_	_	_
23-24	3009-3014	acids	substance	new	_	_
23-25	3015-3016	.	_	_	_	_

#Text=However , in these nanoparticles , at pH 8 , the carboxylate groups are dissociated , giving a negative charge to the surface of the QDs .
24-1	3017-3024	However	_	_	_	_
24-2	3025-3026	,	_	_	_	_
24-3	3027-3029	in	_	_	_	_
24-4	3030-3035	these	object[157]	new[157]	_	_
24-5	3036-3049	nanoparticles	object[157]	new[157]	_	_
24-6	3050-3051	,	_	_	_	_
24-7	3052-3054	at	_	_	_	_
24-8	3055-3057	pH	quantity[158]	new[158]	coref	26-12[173_158]
24-9	3058-3059	8	quantity[158]	new[158]	_	_
24-10	3060-3061	,	_	_	_	_
24-11	3062-3065	the	person[160]	new[160]	coref	26-6[172_160]
24-12	3066-3077	carboxylate	object|person[160]	new|new[160]	_	_
24-13	3078-3084	groups	person[160]	new[160]	_	_
24-14	3085-3088	are	_	_	_	_
24-15	3089-3100	dissociated	_	_	_	_
24-16	3101-3102	,	_	_	_	_
24-17	3103-3109	giving	_	_	_	_
24-18	3110-3111	a	abstract[161]	new[161]	_	_
24-19	3112-3120	negative	abstract[161]	new[161]	_	_
24-20	3121-3127	charge	abstract[161]	new[161]	_	_
24-21	3128-3130	to	_	_	_	_
24-22	3131-3134	the	place[162]	new[162]	_	_
24-23	3135-3142	surface	place[162]	new[162]	_	_
24-24	3143-3145	of	place[162]	new[162]	_	_
24-25	3146-3149	the	place[162]|abstract[163]	new[162]|giv[163]	coref	25-15[167_163]
24-26	3150-3153	QDs	place[162]|abstract[163]	new[162]|giv[163]	_	_
24-27	3154-3155	.	_	_	_	_

#Text=Under these conditions , FA is also negatively charged , and the interaction between the QDs and FA is not favored , due to electrostatic repulsions .
25-1	3156-3161	Under	_	_	_	_
25-2	3162-3167	these	abstract[164]	new[164]	_	_
25-3	3168-3178	conditions	abstract[164]	new[164]	_	_
25-4	3179-3180	,	_	_	_	_
25-5	3181-3183	FA	substance	giv	coref	25-18
25-6	3184-3186	is	_	_	_	_
25-7	3187-3191	also	_	_	_	_
25-8	3192-3202	negatively	_	_	_	_
25-9	3203-3210	charged	_	_	_	_
25-10	3211-3212	,	_	_	_	_
25-11	3213-3216	and	_	_	_	_
25-12	3217-3220	the	abstract[166]	new[166]	_	_
25-13	3221-3232	interaction	abstract[166]	new[166]	_	_
25-14	3233-3240	between	abstract[166]	new[166]	_	_
25-15	3241-3244	the	abstract[166]|abstract[167]	new[166]|giv[167]	coref	26-3[0_167]
25-16	3245-3248	QDs	abstract[166]|abstract[167]	new[166]|giv[167]	_	_
25-17	3249-3252	and	abstract[166]|abstract[167]	new[166]|giv[167]	_	_
25-18	3253-3255	FA	abstract[166]|abstract[167]|substance	new[166]|giv[167]|giv	coref	30-19
25-19	3256-3258	is	_	_	_	_
25-20	3259-3262	not	_	_	_	_
25-21	3263-3270	favored	_	_	_	_
25-22	3271-3272	,	_	_	_	_
25-23	3273-3276	due	_	_	_	_
25-24	3277-3279	to	_	_	_	_
25-25	3280-3293	electrostatic	abstract[169]	new[169]	_	_
25-26	3294-3304	repulsions	abstract[169]	new[169]	_	_
25-27	3305-3306	.	_	_	_	_

#Text=Therefore , QDs coated with amino groups , which , at pH 8 , are positively charged , could improve the analytical characteristics of the sensor .
26-1	3307-3316	Therefore	_	_	_	_
26-2	3317-3318	,	_	_	_	_
26-3	3319-3322	QDs	event	giv	coref	27-23[184_0]
26-4	3323-3329	coated	_	_	_	_
26-5	3330-3334	with	_	_	_	_
26-6	3335-3340	amino	object|person[172]	new|giv[172]	coref|coref|coref|coref	27-11[180_172]|27-26|27-11[180_172]|27-26
26-7	3341-3347	groups	person[172]	giv[172]	_	_
26-8	3348-3349	,	_	_	_	_
26-9	3350-3355	which	_	_	_	_
26-10	3356-3357	,	_	_	_	_
26-11	3358-3360	at	_	_	_	_
26-12	3361-3363	pH	abstract[173]	giv[173]	coref	28-12[191_173]
26-13	3364-3365	8	abstract[173]	giv[173]	_	_
26-14	3366-3367	,	_	_	_	_
26-15	3368-3371	are	_	_	_	_
26-16	3372-3382	positively	_	_	_	_
26-17	3383-3390	charged	_	_	_	_
26-18	3391-3392	,	_	_	_	_
26-19	3393-3398	could	_	_	_	_
26-20	3399-3406	improve	_	_	_	_
26-21	3407-3410	the	abstract[174]	new[174]	coref	32-6[220_174]
26-22	3411-3421	analytical	abstract[174]	new[174]	_	_
26-23	3422-3437	characteristics	abstract[174]	new[174]	_	_
26-24	3438-3440	of	abstract[174]	new[174]	_	_
26-25	3441-3444	the	abstract[174]|object[175]	new[174]|new[175]	coref	31-13[210_175]
26-26	3445-3451	sensor	abstract[174]|object[175]	new[174]|new[175]	_	_
26-27	3452-3453	.	_	_	_	_

#Text=Cysteamine ( CA ) is a bifunctional ligand , with thiol groups that bind strongly to metal ions on the surface of QDs and hydrophilic amino groups that render the QDs biocompatible and dispersible in water .
27-1	3454-3464	Cysteamine	substance	new	coref	27-6[178_0]
27-2	3465-3466	(	_	_	_	_
27-3	3467-3469	CA	object	new	coref	33-16
27-4	3470-3471	)	_	_	_	_
27-5	3472-3474	is	_	_	_	_
27-6	3475-3476	a	substance[178]	giv[178]	_	_
27-7	3477-3489	bifunctional	substance[178]	giv[178]	_	_
27-8	3490-3496	ligand	substance[178]	giv[178]	_	_
27-9	3497-3498	,	substance[178]	giv[178]	_	_
27-10	3499-3503	with	substance[178]	giv[178]	_	_
27-11	3504-3509	thiol	substance[178]|organization|person[180]	giv[178]|new|giv[180]	coref|coref	27-25[186_180]|27-25[186_180]
27-12	3510-3516	groups	substance[178]|person[180]	giv[178]|giv[180]	_	_
27-13	3517-3521	that	_	_	_	_
27-14	3522-3526	bind	_	_	_	_
27-15	3527-3535	strongly	_	_	_	_
27-16	3536-3538	to	_	_	_	_
27-17	3539-3544	metal	substance|substance[182]	new|new[182]	_	_
27-18	3545-3549	ions	substance[182]	new[182]	_	_
27-19	3550-3552	on	substance[182]	new[182]	_	_
27-20	3553-3556	the	substance[182]|place[183]	new[182]|new[183]	_	_
27-21	3557-3564	surface	substance[182]|place[183]	new[182]|new[183]	_	_
27-22	3565-3567	of	substance[182]|place[183]	new[182]|new[183]	_	_
27-23	3568-3571	QDs	substance[182]|place[183]|abstract[184]	new[182]|new[183]|giv[184]	coref	27-30[187_184]
27-24	3572-3575	and	substance[182]|place[183]|abstract[184]	new[182]|new[183]|giv[184]	_	_
27-25	3576-3587	hydrophilic	substance[182]|place[183]|abstract[184]|person[186]	new[182]|new[183]|giv[184]|giv[186]	coref	28-4[190_186]
27-26	3588-3593	amino	substance[182]|place[183]|abstract[184]|object|person[186]	new[182]|new[183]|giv[184]|giv|giv[186]	coref	28-5
27-27	3594-3600	groups	substance[182]|place[183]|abstract[184]|person[186]	new[182]|new[183]|giv[184]|giv[186]	_	_
27-28	3601-3605	that	_	_	_	_
27-29	3606-3612	render	_	_	_	_
27-30	3613-3616	the	abstract[187]	giv[187]	coref	29-7[197_187]
27-31	3617-3620	QDs	abstract[187]	giv[187]	_	_
27-32	3621-3634	biocompatible	abstract[187]	giv[187]	_	_
27-33	3635-3638	and	abstract[187]	giv[187]	_	_
27-34	3639-3650	dispersible	abstract[187]	giv[187]	_	_
27-35	3651-3653	in	_	_	_	_
27-36	3654-3659	water	substance	new	_	_
27-37	3660-3661	.	_	_	_	_

#Text=In addition , the amino groups of CA are protonated at physiological pH and can interact with negatively charged molecules , favoring the formation of a stable assembly by electrostatic interactions .
28-1	3662-3664	In	_	_	_	_
28-2	3665-3673	addition	_	_	_	_
28-3	3674-3675	,	_	_	_	_
28-4	3676-3679	the	person[190]	giv[190]	coref	31-20[213_190]
28-5	3680-3685	amino	object|person[190]	giv|giv[190]	coref	31-20
28-6	3686-3692	groups	person[190]	giv[190]	_	_
28-7	3693-3695	of	_	_	_	_
28-8	3696-3698	CA	_	_	_	_
28-9	3699-3702	are	_	_	_	_
28-10	3703-3713	protonated	_	_	_	_
28-11	3714-3716	at	_	_	_	_
28-12	3717-3730	physiological	quantity[191]	giv[191]	coref	38-15[262_191]
28-13	3731-3733	pH	quantity[191]	giv[191]	_	_
28-14	3734-3737	and	_	_	_	_
28-15	3738-3741	can	_	_	_	_
28-16	3742-3750	interact	_	_	_	_
28-17	3751-3755	with	_	_	_	_
28-18	3756-3766	negatively	object[192]	new[192]	coref	29-15[199_192]
28-19	3767-3774	charged	object[192]	new[192]	_	_
28-20	3775-3784	molecules	object[192]	new[192]	_	_
28-21	3785-3786	,	_	_	_	_
28-22	3787-3795	favoring	_	_	_	_
28-23	3796-3799	the	event[193]	new[193]	_	_
28-24	3800-3809	formation	event[193]	new[193]	_	_
28-25	3810-3812	of	event[193]	new[193]	_	_
28-26	3813-3814	a	event[193]|organization[194]	new[193]|new[194]	_	_
28-27	3815-3821	stable	event[193]|organization[194]	new[193]|new[194]	_	_
28-28	3822-3830	assembly	event[193]|organization[194]	new[193]|new[194]	_	_
28-29	3831-3833	by	event[193]|organization[194]	new[193]|new[194]	_	_
28-30	3834-3847	electrostatic	event[193]|organization[194]|abstract[195]	new[193]|new[194]|new[195]	coref	39-13[268_195]
28-31	3848-3860	interactions	event[193]|organization[194]|abstract[195]	new[193]|new[194]|new[195]	_	_
28-32	3861-3862	.	_	_	_	_

#Text=There are some works based on amino-coated QDs as nanosensors for the determination of different molecules .
29-1	3863-3868	There	_	_	_	_
29-2	3869-3872	are	_	_	_	_
29-3	3873-3877	some	abstract[196]	giv[196]	_	_
29-4	3878-3883	works	abstract[196]	giv[196]	_	_
29-5	3884-3889	based	_	_	_	_
29-6	3890-3892	on	_	_	_	_
29-7	3893-3905	amino-coated	abstract[197]	giv[197]	coref	30-13[204_197]
29-8	3906-3909	QDs	abstract[197]	giv[197]	_	_
29-9	3910-3912	as	abstract[197]	giv[197]	_	_
29-10	3913-3924	nanosensors	abstract[197]	giv[197]	_	_
29-11	3925-3928	for	abstract[197]	giv[197]	_	_
29-12	3929-3932	the	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
29-13	3933-3946	determination	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
29-14	3947-3949	of	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
29-15	3950-3959	different	abstract[197]|abstract[198]|object[199]	giv[197]|new[198]|giv[199]	_	_
29-16	3960-3969	molecules	abstract[197]|abstract[198]|object[199]	giv[197]|new[198]|giv[199]	_	_
29-17	3970-3971	.	_	_	_	_

#Text=However , to our knowledge , there are no reports based on CdTe/CA QDs for the determination of FA .
30-1	3972-3979	However	_	_	_	_
30-2	3980-3981	,	_	_	_	_
30-3	3982-3984	to	_	_	_	_
30-4	3985-3988	our	person|abstract[201]	acc|new[201]	ana|ana	33-5|33-5
30-5	3989-3998	knowledge	abstract[201]	new[201]	_	_
30-6	3999-4000	,	_	_	_	_
30-7	4001-4006	there	_	_	_	_
30-8	4007-4010	are	_	_	_	_
30-9	4011-4013	no	abstract[202]	new[202]	_	_
30-10	4014-4021	reports	abstract[202]	new[202]	_	_
30-11	4022-4027	based	_	_	_	_
30-12	4028-4030	on	_	_	_	_
30-13	4031-4038	CdTe/CA	abstract|abstract[204]	new|giv[204]	coref|coref|coref|coref	31-17[0_204]|34-1|31-17[0_204]|34-1
30-14	4039-4042	QDs	abstract[204]	giv[204]	_	_
30-15	4043-4046	for	_	_	_	_
30-16	4047-4050	the	abstract[205]	giv[205]	coref	33-18[228_205]
30-17	4051-4064	determination	abstract[205]	giv[205]	_	_
30-18	4065-4067	of	abstract[205]	giv[205]	_	_
30-19	4068-4070	FA	abstract[205]|abstract	giv[205]|giv	coref	31-29
30-20	4071-4072	.	_	_	_	_

#Text=Therefore , the objective of the present work is the development of a sensor based on QDs coated with amino groups and its application in the determination of FA in commercial beverages .
31-1	4073-4082	Therefore	_	_	_	_
31-2	4083-4084	,	_	_	_	_
31-3	4085-4088	the	abstract[207]	new[207]	coref	31-10[209_207]
31-4	4089-4098	objective	abstract[207]	new[207]	_	_
31-5	4099-4101	of	abstract[207]	new[207]	_	_
31-6	4102-4105	the	abstract[207]|abstract[208]	new[207]|new[208]	coref	33-2[222_208]
31-7	4106-4113	present	abstract[207]|abstract[208]	new[207]|new[208]	_	_
31-8	4114-4118	work	abstract[207]|abstract[208]	new[207]|new[208]	_	_
31-9	4119-4121	is	_	_	_	_
31-10	4122-4125	the	abstract[209]	giv[209]	_	_
31-11	4126-4137	development	abstract[209]	giv[209]	_	_
31-12	4138-4140	of	abstract[209]	giv[209]	_	_
31-13	4141-4142	a	abstract[209]|object[210]	giv[209]|giv[210]	coref	32-10[221_210]
31-14	4143-4149	sensor	abstract[209]|object[210]	giv[209]|giv[210]	_	_
31-15	4150-4155	based	_	_	_	_
31-16	4156-4158	on	_	_	_	_
31-17	4159-4162	QDs	abstract	giv	ana	31-23
31-18	4163-4169	coated	_	_	_	_
31-19	4170-4174	with	_	_	_	_
31-20	4175-4180	amino	object|person[213]	giv|giv[213]	coref|coref	39-33[276_213]|39-33[276_213]
31-21	4181-4187	groups	person[213]	giv[213]	_	_
31-22	4188-4191	and	person[213]	giv[213]	_	_
31-23	4192-4195	its	person[213]|abstract|abstract[215]	giv[213]|giv|new[215]	coref|coref|coref|coref	33-11[226_0]|42-14[0_215]|33-11[226_0]|42-14[0_215]
31-24	4196-4207	application	person[213]|abstract[215]	giv[213]|new[215]	_	_
31-25	4208-4210	in	person[213]|abstract[215]	giv[213]|new[215]	_	_
31-26	4211-4214	the	person[213]|abstract[215]|abstract[216]	giv[213]|new[215]|new[216]	_	_
31-27	4215-4228	determination	person[213]|abstract[215]|abstract[216]	giv[213]|new[215]|new[216]	_	_
31-28	4229-4231	of	person[213]|abstract[215]|abstract[216]	giv[213]|new[215]|new[216]	_	_
31-29	4232-4234	FA	person[213]|abstract[215]|abstract[216]|substance	giv[213]|new[215]|new[216]|giv	coref	33-21
31-30	4235-4237	in	person[213]|abstract[215]|abstract[216]	giv[213]|new[215]|new[216]	_	_
31-31	4238-4248	commercial	person[213]|abstract[215]|abstract[216]|substance[218]	giv[213]|new[215]|new[216]|giv[218]	coref	41-11[0_218]
31-32	4249-4258	beverages	person[213]|abstract[215]|abstract[216]|substance[218]	giv[213]|new[215]|new[216]|giv[218]	_	_
31-33	4259-4260	.	_	_	_	_

#Text=The proposed design should improve the analytical characteristics of the sensor .
32-1	4261-4264	The	abstract[219]	new[219]	_	_
32-2	4265-4273	proposed	abstract[219]	new[219]	_	_
32-3	4274-4280	design	abstract[219]	new[219]	_	_
32-4	4281-4287	should	_	_	_	_
32-5	4288-4295	improve	_	_	_	_
32-6	4296-4299	the	abstract[220]	giv[220]	_	_
32-7	4300-4310	analytical	abstract[220]	giv[220]	_	_
32-8	4311-4326	characteristics	abstract[220]	giv[220]	_	_
32-9	4327-4329	of	abstract[220]	giv[220]	_	_
32-10	4330-4333	the	abstract[220]|object[221]	giv[220]|giv[221]	_	_
32-11	4334-4340	sensor	abstract[220]|object[221]	giv[220]|giv[221]	_	_
32-12	4341-4342	.	_	_	_	_

#Text=In this work , we present a system based on water-soluble CdTe QDs coated with CA for the determination of FA .
33-1	4343-4345	In	_	_	_	_
33-2	4346-4350	this	abstract[222]	giv[222]	_	_
33-3	4351-4355	work	abstract[222]	giv[222]	_	_
33-4	4356-4357	,	_	_	_	_
33-5	4358-4360	we	person	giv	_	_
33-6	4361-4368	present	_	_	_	_
33-7	4369-4370	a	abstract[224]	new[224]	coref	36-10[250_224]
33-8	4371-4377	system	abstract[224]	new[224]	_	_
33-9	4378-4383	based	_	_	_	_
33-10	4384-4386	on	_	_	_	_
33-11	4387-4400	water-soluble	abstract[226]	giv[226]	coref	35-5[241_226]
33-12	4401-4405	CdTe	substance|abstract[226]	new|giv[226]	coref	35-5
33-13	4406-4409	QDs	abstract[226]	giv[226]	_	_
33-14	4410-4416	coated	_	_	_	_
33-15	4417-4421	with	_	_	_	_
33-16	4422-4424	CA	substance	giv	coref	35-9
33-17	4425-4428	for	_	_	_	_
33-18	4429-4432	the	abstract[228]	giv[228]	coref	36-16[252_228]
33-19	4433-4446	determination	abstract[228]	giv[228]	_	_
33-20	4447-4449	of	abstract[228]	giv[228]	_	_
33-21	4450-4452	FA	abstract[228]|abstract	giv[228]|giv	coref	35-11
33-22	4453-4454	.	_	_	_	_

#Text=CdTe/CA was prepared and characterized by high-resolution transmission electron microscopy , FT-IR spectroscopy , the zeta potential , and UV-visible and fluorescence spectroscopy .
34-1	4455-4462	CdTe/CA	object	giv	coref	36-2
34-2	4463-4466	was	_	_	_	_
34-3	4467-4475	prepared	_	_	_	_
34-4	4476-4479	and	_	_	_	_
34-5	4480-4493	characterized	_	_	_	_
34-6	4494-4496	by	_	_	_	_
34-7	4497-4512	high-resolution	object[231]	new[231]	appos	34-9[233_231]
34-8	4513-4525	transmission	object[231]	new[231]	_	_
34-9	4526-4534	electron	substance|object[233]	new|giv[233]	_	_
34-10	4535-4545	microscopy	object[233]	giv[233]	_	_
34-11	4546-4547	,	object[233]	giv[233]	_	_
34-12	4548-4553	FT-IR	object[233]|abstract|abstract[235]	giv[233]|new|giv[235]	coref|coref	34-20[238_235]|34-20[238_235]
34-13	4554-4566	spectroscopy	object[233]|abstract[235]	giv[233]|giv[235]	_	_
34-14	4567-4568	,	object[233]	giv[233]	_	_
34-15	4569-4572	the	object[233]|abstract[236]	giv[233]|new[236]	coref	42-13[302_236]
34-16	4573-4577	zeta	object[233]|abstract[236]	giv[233]|new[236]	_	_
34-17	4578-4587	potential	object[233]|abstract[236]	giv[233]|new[236]	_	_
34-18	4588-4589	,	object[233]	giv[233]	_	_
34-19	4590-4593	and	object[233]	giv[233]	_	_
34-20	4594-4604	UV-visible	object[233]|abstract[238]	giv[233]|giv[238]	_	_
34-21	4605-4608	and	object[233]|abstract[238]	giv[233]|giv[238]	_	_
34-22	4609-4621	fluorescence	object[233]|abstract|abstract[238]	giv[233]|giv|giv[238]	coref	38-7
34-23	4622-4634	spectroscopy	object[233]|abstract[238]	giv[233]|giv[238]	_	_
34-24	4635-4636	.	_	_	_	_

#Text=The analytical response of CdTe QDs capped with CA toward FA was studied and compared to the results obtained using other thiol-capped QDs .
35-1	4637-4640	The	abstract[239]	new[239]	_	_
35-2	4641-4651	analytical	abstract[239]	new[239]	_	_
35-3	4652-4660	response	abstract[239]	new[239]	_	_
35-4	4661-4663	of	abstract[239]	new[239]	_	_
35-5	4664-4668	CdTe	abstract[239]|substance|abstract[241]	new[239]|giv|giv[241]	coref|coref	35-21[245_241]|35-21[245_241]
35-6	4669-4672	QDs	abstract[239]|abstract[241]	new[239]|giv[241]	_	_
35-7	4673-4679	capped	_	_	_	_
35-8	4680-4684	with	_	_	_	_
35-9	4685-4687	CA	substance	giv	_	_
35-10	4688-4694	toward	_	_	_	_
35-11	4695-4697	FA	substance	giv	coref	36-16
35-12	4698-4701	was	_	_	_	_
35-13	4702-4709	studied	_	_	_	_
35-14	4710-4713	and	_	_	_	_
35-15	4714-4722	compared	_	_	_	_
35-16	4723-4725	to	_	_	_	_
35-17	4726-4729	the	abstract[244]	new[244]	coref	41-4[290_244]
35-18	4730-4737	results	abstract[244]	new[244]	_	_
35-19	4738-4746	obtained	_	_	_	_
35-20	4747-4752	using	_	_	_	_
35-21	4753-4758	other	abstract[245]	giv[245]	coref	36-2[247_245]
35-22	4759-4771	thiol-capped	abstract[245]	giv[245]	_	_
35-23	4772-4775	QDs	abstract[245]	giv[245]	_	_
35-24	4776-4777	.	_	_	_	_

#Text=As CdTe/CA QDs showed the largest quenching efficiency , this system was further studied for FA determination .
36-1	4778-4780	As	_	_	_	_
36-2	4781-4788	CdTe/CA	abstract|abstract[247]	giv|giv[247]	coref|coref|coref|coref	38-10|38-10[260_247]|38-10|38-10[260_247]
36-3	4789-4792	QDs	abstract[247]	giv[247]	_	_
36-4	4793-4799	showed	_	_	_	_
36-5	4800-4803	the	abstract[249]	new[249]	_	_
36-6	4804-4811	largest	abstract[249]	new[249]	_	_
36-7	4812-4821	quenching	abstract|abstract[249]	new|new[249]	coref	38-6[258_0]
36-8	4822-4832	efficiency	abstract[249]	new[249]	_	_
36-9	4833-4834	,	_	_	_	_
36-10	4835-4839	this	abstract[250]	giv[250]	coref	42-1[297_250]
36-11	4840-4846	system	abstract[250]	giv[250]	_	_
36-12	4847-4850	was	_	_	_	_
36-13	4851-4858	further	_	_	_	_
36-14	4859-4866	studied	_	_	_	_
36-15	4867-4870	for	_	_	_	_
36-16	4871-4873	FA	abstract|abstract[252]	giv|giv[252]	coref|coref	38-13[261_0]|38-13[261_0]
36-17	4874-4887	determination	abstract[252]	giv[252]	_	_
36-18	4888-4889	.	_	_	_	_

#Text=The principle of this nanosensor is illustrated in Scheme 1 .
37-1	4890-4893	The	abstract[253]	new[253]	_	_
37-2	4894-4903	principle	abstract[253]	new[253]	_	_
37-3	4904-4906	of	abstract[253]	new[253]	_	_
37-4	4907-4911	this	abstract[253]|object[254]	new[253]|new[254]	coref	40-1[284_254]
37-5	4912-4922	nanosensor	abstract[253]|object[254]	new[253]|new[254]	_	_
37-6	4923-4925	is	_	_	_	_
37-7	4926-4937	illustrated	_	_	_	_
37-8	4938-4940	in	_	_	_	_
37-9	4941-4947	Scheme	abstract[255]	new[255]	_	_
37-10	4948-4949	1	abstract[255]	new[255]	_	_
37-11	4950-4951	.	_	_	_	_

#Text=The probe is based on the fluorescence quenching of CdTe/CA QDs by FA at pH 8 .
38-1	4952-4955	The	object[256]	new[256]	_	_
38-2	4956-4961	probe	object[256]	new[256]	_	_
38-3	4962-4964	is	_	_	_	_
38-4	4965-4970	based	_	_	_	_
38-5	4971-4973	on	_	_	_	_
38-6	4974-4977	the	abstract[258]	giv[258]	coref	39-5[265_258]
38-7	4978-4990	fluorescence	abstract|abstract[258]	giv|giv[258]	coref	39-5
38-8	4991-5000	quenching	abstract[258]	giv[258]	_	_
38-9	5001-5003	of	abstract[258]	giv[258]	_	_
38-10	5004-5011	CdTe/CA	abstract[258]|substance|abstract[260]	giv[258]|giv|giv[260]	coref|coref|coref|coref	39-18|39-16[270_260]|39-18|39-16[270_260]
38-11	5012-5015	QDs	abstract[258]|abstract[260]	giv[258]|giv[260]	_	_
38-12	5016-5018	by	abstract[258]|abstract[260]	giv[258]|giv[260]	_	_
38-13	5019-5021	FA	abstract[258]|abstract[260]|abstract[261]	giv[258]|giv[260]|giv[261]	coref	39-31[0_261]
38-14	5022-5024	at	abstract[258]|abstract[260]|abstract[261]	giv[258]|giv[260]|giv[261]	_	_
38-15	5025-5027	pH	abstract[258]|abstract[260]|abstract[261]|abstract[262]	giv[258]|giv[260]|giv[261]|giv[262]	_	_
38-16	5028-5029	8	abstract[258]|abstract[260]|abstract[261]|abstract[262]	giv[258]|giv[260]|giv[261]|giv[262]	_	_
38-17	5030-5031	.	_	_	_	_

#Text=A probable mechanism of fluorescence quenching based on the coordinated behavior of electrostatic interactions between positively charged CdTe/CA QDs ( ethylamine groups , pKa = 10.52 ) and negatively charged FA ( carboxylic groups , pKaα = 3.46 and pKaγ = 4.83 ) and the electronic transfer of QDs to FA is proposed .
39-1	5032-5033	A	abstract[263]	new[263]	_	_
39-2	5034-5042	probable	abstract[263]	new[263]	_	_
39-3	5043-5052	mechanism	abstract[263]	new[263]	_	_
39-4	5053-5055	of	abstract[263]	new[263]	_	_
39-5	5056-5068	fluorescence	abstract[263]|abstract|abstract[265]	new[263]|giv|giv[265]	_	_
39-6	5069-5078	quenching	abstract[263]|abstract[265]	new[263]|giv[265]	_	_
39-7	5079-5084	based	_	_	_	_
39-8	5085-5087	on	_	_	_	_
39-9	5088-5091	the	abstract[266]	new[266]	_	_
39-10	5092-5103	coordinated	abstract[266]	new[266]	_	_
39-11	5104-5112	behavior	abstract[266]	new[266]	_	_
39-12	5113-5115	of	abstract[266]	new[266]	_	_
39-13	5116-5129	electrostatic	abstract[266]|abstract|abstract[268]	new[266]|new|giv[268]	_	_
39-14	5130-5142	interactions	abstract[266]|abstract[268]	new[266]|giv[268]	_	_
39-15	5143-5150	between	abstract[266]|abstract[268]	new[266]|giv[268]	_	_
39-16	5151-5161	positively	abstract[266]|abstract[268]|substance[270]	new[266]|giv[268]|giv[270]	appos	39-21[272_270]
39-17	5162-5169	charged	abstract[266]|abstract[268]|substance[270]	new[266]|giv[268]|giv[270]	_	_
39-18	5170-5177	CdTe/CA	abstract[266]|abstract[268]|substance|substance[270]	new[266]|giv[268]|giv|giv[270]	_	_
39-19	5178-5181	QDs	abstract[266]|abstract[268]|substance[270]	new[266]|giv[268]|giv[270]	_	_
39-20	5182-5183	(	_	_	_	_
39-21	5184-5194	ethylamine	abstract|substance[272]	new|giv[272]	coref|coref	39-49[0_272]|39-49[0_272]
39-22	5195-5201	groups	substance[272]	giv[272]	_	_
39-23	5202-5203	,	_	_	_	_
39-24	5204-5207	pKa	substance	new	_	_
39-25	5208-5209	=	_	_	_	_
39-26	5210-5215	10.52	quantity	new	_	_
39-27	5216-5217	)	_	_	_	_
39-28	5218-5221	and	_	_	_	_
39-29	5222-5232	negatively	_	_	_	_
39-30	5233-5240	charged	_	_	_	_
39-31	5241-5243	FA	substance	giv	coref	39-51
39-32	5244-5245	(	_	_	_	_
39-33	5246-5256	carboxylic	person[276]	giv[276]	_	_
39-34	5257-5263	groups	person[276]	giv[276]	_	_
39-35	5264-5265	,	_	_	_	_
39-36	5266-5270	pKaα	quantity	new	_	_
39-37	5271-5272	=	_	_	_	_
39-38	5273-5277	3.46	quantity	new	_	_
39-39	5278-5281	and	_	_	_	_
39-40	5282-5286	pKaγ	abstract	new	_	_
39-41	5287-5288	=	_	_	_	_
39-42	5289-5293	4.83	quantity	new	_	_
39-43	5294-5295	)	_	_	_	_
39-44	5296-5299	and	_	_	_	_
39-45	5300-5303	the	abstract[281]	new[281]	_	_
39-46	5304-5314	electronic	abstract[281]	new[281]	_	_
39-47	5315-5323	transfer	abstract[281]	new[281]	_	_
39-48	5324-5326	of	abstract[281]	new[281]	_	_
39-49	5327-5330	QDs	abstract[281]|substance	new[281]|giv	_	_
39-50	5331-5333	to	abstract[281]	new[281]	_	_
39-51	5334-5336	FA	abstract[281]|substance	new[281]|giv	coref	41-8
39-52	5337-5339	is	_	_	_	_
39-53	5340-5348	proposed	_	_	_	_
39-54	5349-5350	.	_	_	_	_

#Text=The nanosensor is rapid , easy to obtain , and shows a low detection limit , high selectivity , and low cost .
40-1	5351-5354	The	object[284]	giv[284]	_	_
40-2	5355-5365	nanosensor	object[284]	giv[284]	_	_
40-3	5366-5368	is	_	_	_	_
40-4	5369-5374	rapid	_	_	_	_
40-5	5375-5376	,	_	_	_	_
40-6	5377-5381	easy	_	_	_	_
40-7	5382-5384	to	_	_	_	_
40-8	5385-5391	obtain	_	_	_	_
40-9	5392-5393	,	_	_	_	_
40-10	5394-5397	and	_	_	_	_
40-11	5398-5403	shows	_	_	_	_
40-12	5404-5405	a	abstract[286]	new[286]	_	_
40-13	5406-5409	low	abstract[286]	new[286]	_	_
40-14	5410-5419	detection	abstract|abstract[286]	giv|new[286]	_	_
40-15	5420-5425	limit	abstract[286]	new[286]	_	_
40-16	5426-5427	,	_	_	_	_
40-17	5428-5432	high	abstract[287]	new[287]	_	_
40-18	5433-5444	selectivity	abstract[287]	new[287]	_	_
40-19	5445-5446	,	_	_	_	_
40-20	5447-5450	and	_	_	_	_
40-21	5451-5454	low	abstract[288]	new[288]	_	_
40-22	5455-5459	cost	abstract[288]	new[288]	_	_
40-23	5460-5461	.	_	_	_	_

#Text=The method showed excellent results in detecting FA contents in beverages ( recoveries from 98.3 to 103.9 % ) .
41-1	5462-5465	The	abstract[289]	new[289]	_	_
41-2	5466-5472	method	abstract[289]	new[289]	_	_
41-3	5473-5479	showed	_	_	_	_
41-4	5480-5489	excellent	abstract[290]	giv[290]	_	_
41-5	5490-5497	results	abstract[290]	giv[290]	_	_
41-6	5498-5500	in	_	_	_	_
41-7	5501-5510	detecting	_	_	_	_
41-8	5511-5513	FA	substance|object[292]	giv|new[292]	_	_
41-9	5514-5522	contents	object[292]	new[292]	_	_
41-10	5523-5525	in	_	_	_	_
41-11	5526-5535	beverages	substance	giv	_	_
41-12	5536-5537	(	_	_	_	_
41-13	5538-5548	recoveries	event[294]	new[294]	_	_
41-14	5549-5553	from	event[294]	new[294]	_	_
41-15	5554-5558	98.3	event[294]|quantity[295]	new[294]|new[295]	_	_
41-16	5559-5561	to	event[294]|quantity[295]	new[294]|new[295]	_	_
41-17	5562-5567	103.9	event[294]|quantity[295]|quantity[296]	new[294]|new[295]|new[296]	_	_
41-18	5568-5569	%	event[294]|quantity[295]|quantity[296]	new[294]|new[295]|new[296]	_	_
41-19	5570-5571	)	_	_	_	_
41-20	5572-5573	.	_	_	_	_

#Text=The system provides a new approach for the construction of nanosensors with high application potential in different areas .
42-1	5574-5577	The	abstract[297]	giv[297]	_	_
42-2	5578-5584	system	abstract[297]	giv[297]	_	_
42-3	5585-5593	provides	_	_	_	_
42-4	5594-5595	a	abstract[298]	new[298]	_	_
42-5	5596-5599	new	abstract[298]	new[298]	_	_
42-6	5600-5608	approach	abstract[298]	new[298]	_	_
42-7	5609-5612	for	abstract[298]	new[298]	_	_
42-8	5613-5616	the	abstract[298]|abstract[299]	new[298]|new[299]	_	_
42-9	5617-5629	construction	abstract[298]|abstract[299]	new[298]|new[299]	_	_
42-10	5630-5632	of	abstract[298]|abstract[299]	new[298]|new[299]	_	_
42-11	5633-5644	nanosensors	abstract[298]|abstract[299]|object[300]	new[298]|new[299]|new[300]	_	_
42-12	5645-5649	with	abstract[298]|abstract[299]|object[300]	new[298]|new[299]|new[300]	_	_
42-13	5650-5654	high	abstract[298]|abstract[299]|object[300]|abstract[302]	new[298]|new[299]|new[300]|giv[302]	_	_
42-14	5655-5666	application	abstract[298]|abstract[299]|object[300]|abstract|abstract[302]	new[298]|new[299]|new[300]|giv|giv[302]	_	_
42-15	5667-5676	potential	abstract[298]|abstract[299]|object[300]|abstract[302]	new[298]|new[299]|new[300]|giv[302]	_	_
42-16	5677-5679	in	abstract[298]|abstract[299]|object[300]|abstract[302]	new[298]|new[299]|new[300]|giv[302]	_	_
42-17	5680-5689	different	abstract[298]|abstract[299]|object[300]|abstract[302]|abstract[303]	new[298]|new[299]|new[300]|giv[302]|new[303]	_	_
42-18	5690-5695	areas	abstract[298]|abstract[299]|object[300]|abstract[302]|abstract[303]	new[298]|new[299]|new[300]|giv[302]|new[303]	_	_
42-19	5696-5697	.	_	_	_	_
